Safety and tolerability of deferoxamine mesylate in patients with acute intracerebral hemorrhage.
Selim M, Yeatts S, Goldstein JN, Gomes J, Greenberg S, Morgenstern LB, Schlaug G, Torbey M, Waldman B, Xi G, Palesch Y; Deferoxamine Mesylate in Intracerebral Hemorrhage Investigators.
Selim M, et al. Among authors: goldstein jn.
Stroke. 2011 Nov;42(11):3067-74. doi: 10.1161/STROKEAHA.111.617589. Epub 2011 Aug 25.
Stroke. 2011.
PMID: 21868742
Free PMC article.
Clinical Trial.